Cerebrolysin
Pig-brain-derived peptide complex
A broad neurotrophic cocktail.
Half-life
~ several hours
Mol. weight
Mixed (low-molecular-weight peptides <10 kDa)
Sequence
Complex peptide/amino-acid mixture (porcine-derived)
Discussions
0 threads
Overview
A complex of low-molecular-weight peptides and amino acids derived from purified porcine brain tissue, studied and used (primarily in Europe and Asia) for neurodegenerative conditions, stroke recovery, and traumatic brain injury. It is a heterogeneous mixture rather than a single peptide, intended to mimic endogenous neurotrophic factors like BDNF, NGF, and GDNF.
Mechanism of action
Cerebrolysin is a peptide/amino-acid complex designed to exert neurotrophic effects analogous to endogenous factors like BDNF, nerve growth factor (NGF), and glial-cell-line-derived neurotrophic factor (GDNF). Its components support neuronal survival, synaptic plasticity, and neurogenesis, and it has been studied for reducing ischemic damage and supporting recovery after stroke and TBI. Because it is a mixture, its effects are broad rather than targetable to a single receptor — both its strength (multimodal neuroprotection) and its limitation (ill-defined mechanism).
Researched benefits
- Multimodal neurotrophic support (BDNF/NGF/GDNF-like)
- Studied for stroke recovery and TBI
- Used clinically in several countries for neurodegeneration
Considerations
- Heterogeneous mixture — mechanism not fully characterized
- Not FDA-approved in the US
- Quality and sourcing critical
Key Academic Literature & Studies
Search more in PubMedPeer-reviewed citations and clinical trials evaluating Cerebrolysin in scientific literature.
Query PubMed for recent peer-reviewed preclinical and clinical publications on Cerebrolysin:
View Cerebrolysin index on PubMed (NCBI)